Inference Investigation

Claim investigated: Verification of specific SEC filings requires direct access to SEC EDGAR database to confirm current filing status and any material disclosures Entity: HPSP Original confidence: inferential Result: CONTRADICTED → PRIMARY

Assessment

The inferential claim is technically accurate but fundamentally misapplied to the entity under investigation. SEC EDGAR access is indeed required to verify SEC filings—but HPSP the Korean semiconductor company (KOSDAQ: 403870) has no SEC filing obligations whatsoever. The claim appears to be a residual artifact from earlier research conflating HPSP with HealthStream Inc. (formerly NASDAQ: HPSP). This represents a critical jurisdictional error: Korean KOSDAQ-listed companies file with Korea's Financial Supervisory Service via DART, not the US SEC.

Reasoning: The claim is self-contradicting when applied to the specified entity. HPSP (KOSDAQ: 403870) is a Korean corporation listed on KOSDAQ since 2022, placing it exclusively under Korean FSS jurisdiction. SEC filing requirements under the Securities Exchange Act of 1934 apply only to: (1) US domestic issuers, (2) foreign private issuers with US-listed securities or meeting shareholder thresholds, or (3) entities making US public offerings. None of these conditions apply to HPSP. The correct regulatory database is Korea's DART system (dart.fss.or.kr), where HPSP's filings can be verified. This can be elevated to PRIMARY confidence because KOSDAQ listing requirements and SEC jurisdictional boundaries are matters of statutory record.

Underreported Angles

• Crescendo Equity Partners' 39.42% controlling stake in HPSP warrants investigation—if Crescendo operates SEC-registered investment advisers or funds with US investors, HPSP holdings may appear in Form ADV, 13F, or fund disclosure documents, creating an indirect US regulatory footprint
• HPSP's claim to be the 'world's only manufacturer' of high-pressure hydrogen annealing equipment should be verifiable through USPTO/EPO/KIPO patent searches—monopoly claims in semiconductor equipment are rare and would indicate significant IP moat or potential antitrust considerations
• US CHIPS Act implementation may create indirect federal spending records if US semiconductor fabs (Intel, TSMC Arizona, Samsung Texas) purchase HPSP equipment using subsidized funds—equipment procurement disclosures could surface HPSP as a supplier
• Samsung Electronics and SK Hynix are likely HPSP customers given the hydrogen annealing process relevance to advanced memory manufacturing—their US subsidiary SEC filings (Samsung Austin Semiconductor, SK Hynix America) may reference HPSP as a material supplier

Public Records to Check

• SEC EDGAR: Full-text search: 'HPSP' OR 'high-pressure hydrogen annealing' in 10-K, 10-Q, 8-K filings Would identify if any US semiconductor companies (Intel, Micron, GlobalFoundries) or Korean company US subsidiaries disclose HPSP as equipment supplier or material vendor

• SEC EDGAR: Crescendo Equity Partners Form ADV, Form 13F filings If Crescendo operates US-registered investment vehicles, their 39.42% HPSP stake may appear in US regulatory filings, creating verifiable US documentation of the Korean company

• other: Korea DART (dart.fss.or.kr): Search '에이치피에스피' (HPSP Korean name) or stock code 403870 Direct verification of HPSP's actual regulatory filings, financial statements, and material disclosures in the correct jurisdiction

• USASpending: CHIPS Act awards; recipient equipment supplier disclosures; HPSP or hydrogen annealing equipment Would reveal if HPSP equipment enters US federal spending chain through CHIPS-subsidized semiconductor facilities

• other: USPTO/EPO patent search: 'high pressure hydrogen annealing' semiconductor; assignee HPSP Would verify or challenge HPSP's 'world's only manufacturer' market position claim through IP documentation

• SEC EDGAR: HealthStream Inc. (HSTM) current filings to confirm former ticker symbol history Would clarify the source of original HPSP/SEC confusion and confirm HealthStream's ticker history

Significance

SIGNIFICANT — This finding exposes a fundamental research methodology error that has propagated through the established facts database—conflating multiple unrelated entities sharing the HPSP acronym. For investigators researching the Korean semiconductor company, pursuing SEC EDGAR would yield zero relevant results while the correct database (Korea DART) remains unqueried. This jurisdictional confusion could lead to false negative conclusions about HPSP's regulatory compliance or disclosure practices. The finding is significant because it redirects investigation toward productive sources and identifies indirect pathways (Crescendo holdings, US customer disclosures, CHIPS Act procurement) where HPSP might actually appear in US records.